Tenon Medical, Inc. (TNON)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenue | 564 | 887 | 901 | |
| Cost of sales | 319 | 469 | 431 | |
| Gross profit | 245 | 418 | 470 | |
| Sales and marketing | 1,119 | 1,212 | 1,448 | |
| Research and development | 503 | 657 | 708 | |
| General and administrative | 1,480 | 1,764 | 2,186 | |
| Total operating expenses | 3,102 | 3,633 | 4,342 | |
| Loss from operations | -2,857 | -3,215 | -3,872 | |
| Other income (expense), net | - | - | 7 | |
| Interest expense | - | - | - | |
| Gain on investments | 88 | 31 | 39 | |
| Total other income (expense), net | 88 | 31 | 46 | |
| Net loss | -2,769 | -3,184 | -3,826 | |
| Foreign currency translation adjustment | - | - | - | |
| Total comprehensive loss | -2,769 | -3,184 | -3,826 | |
| Basic (in dollars per share) | -0.36 | -3.63 | -1.02 | |
| Basic (in shares) | 7,591 | 877 | 3,749 | |
| Diluted (in dollars per share) | -0.36 | -3.63 | -1.02 | |
| Diluted (in shares) | 7,591 | 877 | 3,749 | |